ARIZ Precision Medicine
Davis
About ARIZ Precision Medicine
ARIZ Precision Medicine is a biotechnology company that develops drug candidates for cancer.The acronym stands for a methodology of solving big problems, by breaking the big problem into smaller and smaller problems. This way the company can start at the beginning, the cause of cancer and design drugs that can resolve a specific individual cancer as well as all cancers. ARIZ Precision Medicine uses this methodology to design a specific way to stop the cause of cancer, then target and protect the delivery system and finally, concentrate the drug inside the cancer cell leaving normal cells undamaged.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.7M
- Funding stage: Seed
- Last round: Convertible Note (Mar 2022)
- Website: arizbio.com
- Phone: +1 408 656 3542
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/ariz-precision-medicine-107680 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.